Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor β signaling
Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor β signaling
复制标题
DOI:
10.1158/0008-5472.can-07-2706
复制
发表时间:
2008-03-01
期刊:
影响因子:
11.2
通讯作者:
Breier, Georg
中科院分区:
文献类型:
--
作者:
Labelle, Myriam;Schnittler, Hans J.;Breier, Georg
Epithelial-to-mesenchymal transition (EMT) is an important event during carcinoma progression and leads to increased tumor cell malignancy. Here, we show that vascular endothelial (VE)-cadherin is induced during EMT in mammary tumor cells and is aberrantly expressed in invasive human breast carcinomas. VE-cadherin enhanced the capacity of fibroblastoid tumor cells to proliferate, form cord-like invasive structures, and adhere to endothelial cells, characteristics that are key contributors to their increased malignancy and metastatic potential. Consistently, VE-cadherin expression in malignant fibroblastoid tumor cells promoted the growth of experimental mammary carcinomas in vivo. Analysis of the signaling mechanisms involved revealed that VE-cadherin expression influences the levels of Smad2 phosphorylation and expression of target genes of transforming growth factor-beta (TGF-beta), a major mediator of advanced tumor progression and malignant tumor cell proliferation. VE-cadherin might thus promote tumor progression not only by contributing to tumor anaiogenesis but also by enhancing tumor cell proliferation via the TGF-beta signaling pathway. This article provides evidence for a novel function of VE-cadherin in tumor progression and reveals a previously unknown molecular link between VE-cadherin expression and TGF- signaling. Our findings may have important implications for the clinical application of anti-VE-cadherin strategies.